Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012–2015

[1]  F. Yu,et al.  Clinical and microbiological characteristics of pyogenic liver abscess in a tertiary hospital in East China , 2017, Medicine.

[2]  M. Scrascia,et al.  Carbapenemases‐producing Klebsiella pneumoniae in hospitals of two regions of Southern Italy , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  V. di Pilato,et al.  Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review , 2017, Virulence.

[4]  D. Yong,et al.  Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015 , 2017, Annals of laboratory medicine.

[5]  P. Tamma,et al.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Y. Chuang,et al.  The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis , 2016, Scientific Reports.

[7]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[8]  Young Bae Kim,et al.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..

[9]  I. Spiliopoulou,et al.  A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates. , 2016, Journal of medical microbiology.

[10]  C. Clancy,et al.  Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae , 2016, Antimicrobial Agents and Chemotherapy.

[11]  J. M. Azcona,et al.  Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain. , 2016, The Journal of infection.

[12]  B. Limbago,et al.  The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection , 2016, Journal of Clinical Microbiology.

[13]  H. Grundmann,et al.  Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey , 2015, PloS one.

[14]  R. Lynfield,et al.  Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. , 2015, JAMA.

[15]  C. Viscoli,et al.  Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy , 2015, BMC Infectious Diseases.

[16]  Y. Chuang,et al.  Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan , 2015, PloS one.

[17]  J. Mu,et al.  Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013 , 2015, PloS one.

[18]  J. Mingorance,et al.  Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone. , 2015, International journal of antimicrobial agents.

[19]  C. Ki,et al.  Klebsiella pneumoniae Co-Producing NDM-5 and OXA-181 Carbapenemases, South Korea , 2015, Emerging infectious diseases.

[20]  Y. Chuang,et al.  Emergence of KPC new variants (KPC-16 and KPC-17) and ongoing outbreak in southern Taiwan. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  Shan-Chwen Chang,et al.  Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan , 2015, PloS one.

[22]  C. Nikam,et al.  Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[23]  Y. Chuang,et al.  Identification of the first imported KPC-3 Klebsiella pneumoniae from the USA to Taiwan. , 2014, International journal of antimicrobial agents.

[24]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  F. DeLeo,et al.  Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain , 2014, mBio.

[26]  Y. Chuang,et al.  KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. , 2014, The Journal of antimicrobial chemotherapy.

[27]  Y. Doi,et al.  Co-Production of NDM-1 and OXA-232 by Klebsiella pneumoniae , 2014, Emerging infectious diseases.

[28]  Hui Wang,et al.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. , 2013, The Lancet. Infectious diseases.

[29]  P. Nordmann,et al.  Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  Y. Chuang,et al.  National Surveillance Study on Carbapenem Non-Susceptible Klebsiella pneumoniae in Taiwan: The Emergence and Rapid Dissemination of KPC-2 Carbapenemase , 2013, PloS one.

[31]  Ronald N. Jones,et al.  Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. , 2013, Diagnostic microbiology and infectious disease.

[32]  Chang-Phone Fung,et al.  Klebsiella pneumoniae liver abscess: a new invasive syndrome. , 2012, The Lancet. Infectious diseases.

[33]  Wen-Sen Lee,et al.  Outbreak of Klebsiella pneumoniae Carbapenemase-2-Producing K. pneumoniae Sequence Type 11 in Taiwan in 2011 , 2012, Antimicrobial Agents and Chemotherapy.

[34]  A. Haidich,et al.  Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. , 2011, The Lancet. Infectious diseases.

[35]  N. Lee,et al.  Molecular Typing and Virulence Analysis of Serotype K1 Klebsiella pneumoniae Strains Isolated from Liver Abscess Patients and Stool Samples from Noninfectious Subjects in Hong Kong, Singapore, and Taiwan , 2011, Journal of Clinical Microbiology.

[36]  Robert A. Bonomo,et al.  Carbapenems: Past, Present, and Future , 2011, Antimicrobial Agents and Chemotherapy.

[37]  P. Hsueh,et al.  Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. , 2011, The Journal of antimicrobial chemotherapy.

[38]  Y. Qi,et al.  ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. , 2011, The Journal of antimicrobial chemotherapy.

[39]  Shou-Dong Lee,et al.  First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. , 2010, Journal of the Chinese Medical Association : JCMA.

[40]  K. Mathee,et al.  Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[41]  K. Riesenberg,et al.  Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia , 2009, Infection Control & Hospital Epidemiology.

[42]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[43]  Y. Carmeli,et al.  Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258 , 2009, Antimicrobial Agents and Chemotherapy.

[44]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.

[45]  F. Schmidt.  Meta-Analysis , 2008 .

[46]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[47]  J. Turnidge,et al.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.

[48]  John Quale,et al.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. , 2005, Archives of internal medicine.

[49]  P. Nordmann,et al.  Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.

[50]  J. Wu,et al.  Identification of a Plasmid Encoding SHV-12, TEM-1, and a Variant of IMP-2 Metallo-β-Lactamase, IMP-8, from a Clinical Isolate of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[51]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[52]  D. Gu,et al.  A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. , 2018, The Lancet. Infectious diseases.

[53]  B. Cao,et al.  Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. , 2014, Diagnostic microbiology and infectious disease.

[54]  P. Lu,et al.  Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. , 2013, Journal of medical microbiology.

[55]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[56]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .